OpenAI’s October 30 release notes introduced GPT-6 Rosalind Research for multistep life sciences work. This is a review of that announcement, not a new November release. Rollout is limited to approved Research organizations and authorized users in Work, Codex and the API; it is unavailable in the Chat tab.

Research approval is model-specific

Discovery approval does not grant Research access. Rosalind Discovery remains on 5.5, and GPT-5.5 Rosalind Research remains usable. The GPT-6 API identifier is gpt-6-rosalind; API access requires an approved API organization.

Enterprise rollout starts with a two-week Admin Preview, off by default. Administrators can enable approved Research users. Buying a regular subscription or accessing Rosalind Workbench does not establish access to this model.